Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Drug & Device News
Risperdal Suits Heading To Trial
Two new trials against Janssen Pharmaceuticals over its anti-psychotic drug Risperdal are set for hearing this month. The cases, which are being tried on the plaintiff side by Thomas R. Kline of Kline and Specter and by Christopher A. Gomez and Stephen A. Sheller of Sheller P.C., claim that the company failed to warn the plaintiffs of the risk of developing gynecomastia, a condition in which males develop enlarged breasts. One previous case was settled pre-trial and another was decided in favor of the plaintiff, while in a third, the jury found Janssen negligent for failing to warn of the potential for abnormal breast development, yet also found that the plaintiff's particular breast development was not caused by Risperdal.
'
Eli Lilly Wins in First Bellwether Trial over Alleged Cymbalta Injuries
On Aug. 7, a federal jury rejected plaintiff Claudia Herrera's claim that she was injured because Eli Lilly and Co. failed to disclose that 44% of participants in clinical trials of their drug Cymbalta experienced withdrawal symptoms. Side effects claimed by the plaintiffs included electrical sensations in the brain (called “brain-zaps” in court filings), dizziness, nausea, vomiting, sweating, insomnia, nightmares and diarrhea. Cymbalta is used to treat depression, anxiety, fibromyalgia and pain. According to Eli Lilly's July U.S. Securities and Exchange Commission (SEC) quarterly filing, the company is currently facing about 65 lawsuits concerning Cymbalta.
'
Risperdal Suits Heading To Trial
Two new trials against
'
Eli Lilly Wins in First Bellwether Trial over Alleged Cymbalta Injuries
On Aug. 7, a federal jury rejected plaintiff Claudia Herrera's claim that she was injured because Eli Lilly and Co. failed to disclose that 44% of participants in clinical trials of their drug Cymbalta experienced withdrawal symptoms. Side effects claimed by the plaintiffs included electrical sensations in the brain (called “brain-zaps” in court filings), dizziness, nausea, vomiting, sweating, insomnia, nightmares and diarrhea. Cymbalta is used to treat depression, anxiety, fibromyalgia and pain. According to Eli Lilly's July U.S. Securities and Exchange Commission (SEC) quarterly filing, the company is currently facing about 65 lawsuits concerning Cymbalta.
'
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
'Huguenot LLC v. Megalith Capital Group Fund I, L.P.': A Tutorial On Contract Liability for Real Estate Purchasers
In June 2024, the First Department decided Huguenot LLC v. Megalith Capital Group Fund I, L.P., which resolved a question of liability for a group of condominium apartment buyers and in so doing, touched on a wide range of issues about how contracts can obligate purchasers of real property.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
CoStar Wins Injunction for Breach-of-Contract Damages In CRE Database Access Lawsuit
Latham & Watkins helped the largest U.S. commercial real estate research company prevail in a breach-of-contract dispute in District of Columbia federal court.